Ramipril Tablets bulk supplier for pharma manufacturers

Ramipril Tablets 1.25 mg, 2.5 mg, 5 mg, 10 mg Suppliers & Bulk Manufacturers

Available Forms: Tablets

Available Strengths: 1.25 mg, 2.5 mg, 5 mg, 10 mg

Reference Brands: Tritace (EU)

Ramipril tablets 1.25 mg, 2.5 mg, 5 mg and 10 mg, an ACE inhibitor for hypertension, heart failure and cardiovascular risk, for importers, distributors, hospital pharmacies and tender buyers.

Get Enquiry / Request Bulk Quote

Usually answered within 48 hours | GMP documents shared before you commit

Manufacture or export Ramipril Tablets? List it or send an offer →

Product Description:

Ramipril is an angiotensin-converting enzyme (ACE) inhibitor. It is a prodrug, converted in the liver to ramiprilat, which stops the formation of angiotensin II. Blood vessels relax, aldosterone falls, and the load on heart and kidneys eases. This page covers ramipril tablets at 1.25 mg, 2.5 mg, 5 mg and 10 mg. The low strengths allow a cautious start in heart failure and older patients, then step-wise increases.

Ramipril is used for hypertension, heart failure, heart failure after a heart attack, and to cut cardiovascular risk in people with established vascular disease or high-risk diabetes. Dosing is once daily, starting low because the first dose can drop blood pressure, especially with diuretics. Kidney function and potassium are checked before starting and after dose changes. Dry cough is common; angioedema, though rare, means ACE inhibitors are stopped for good. Ramipril is contraindicated in pregnancy and with sacubitril/valsartan. NSAIDs, potassium supplements and potassium-sparing diuretics need care.

Sourcing notes. Ramipril is a prescription-only generic with pharmacopoeial monographs. It degrades with heat, moisture and compression to a diketopiperazine impurity and ramiprilat, so ask how the formulation is stabilised and check related substances in the stability data, especially zone IVb for hot humid markets. Cold-form aluminium blisters give the strongest moisture barrier. Ask for a CTD or ACTD dossier with bioequivalence data, a CoA per batch covering assay, impurities, dissolution and uniformity, plus the GMP certificate and a CoPP. Regulators expect a nitrosamine risk assessment, and ramipril's secondary amine makes it relevant.

Also known as: ramipril (French, Italian), Ramipril (German), рамиприл (Russian), راميبريل (Arabic), 雷米普利 (Chinese), ラミプリル (Japanese).

Ramipril Tablets — third party manufacturing & bulk supply

Ramipril Tablets 1.25 mg, 2.5 mg, 5 mg, 10 mg is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.

Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.

Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Ramipril Tablets is supplied as Tablets — an oral solid dosage form, so the indicative MOQ is 200,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Ramipril Tablets listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Ramipril Tablets →

Usually answered within 48 hours, with matched manufacturers, indicative prices and document status.

Back to Listing

Frequently Asked Questions

Ramipril Tablets are used to treat high blood pressure (hypertension), manage heart failure, reduce the risk of heart attack and stroke, and protect kidney function in patients with diabetes or other kidney-related conditions.

Ramipril is an angiotensin-converting enzyme (ACE) inhibitor that blocks the conversion of angiotensin I to angiotensin II, a substance that narrows blood vessels. This relaxation of blood vessels lowers blood pressure and reduces strain on the heart.

The primary trade name is Altace, along with multiple generic brands available worldwide.

Ramipril was originally developed and marketed by AstraZeneca and is now manufactured by several pharmaceutical companies globally as a generic medicine.

The generic name is Ramipril.

Brand names include Altace and various regional generic brands.

Ramipril Tablets are manufactured globally, including in the USA, Europe, India, and other regions, by multiple pharmaceutical companies under approved regulatory standards.